Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.
The serum and urine concentrations of fibrin/fibrinogen degradation products (F.D.P.) were estimated in 172 patients with glomerulonephritis. In each case the diagnosis was established on the basis of clinical, renal histological, and ultrastructural findings. Serum F.D.P. concentrations were often raised in all types of glomerulonephritis, though more consistently in active proliferative forms. The urinary concentration provided a reliable and sensitive index of activity, progression, and natural history in proliferative glomerulonephritis. In these forms the urinary F.D.P. content was thought to reflect predominantly lysis of intraglomerular fibrin deposits. In minimal lesion and membranous glomerulonephritis low but abnormal concentrations of urinary F.D.P. were consistently found. It is suggested that in these cases the products are derived from limited proteolysis of fibrinogen filtered through an abnormally permeable basement membrane.Daily measurement of urinary F.D.P. concentration is of potential value in the differential diagnosis of patients with glomerulonephritis and at the same time provides a sensitive assessment of the activity and natural history of proliferative disease.
D001485:Basement Membrane / Q000378:metabolism; D001706:Biopsy; D003404:Creatinine / Q000097:blood; D003937:Diagnosis, Differential; D005337:Fibrin / Q000097:blood* / Q000652:urine*; D005340:Fibrinogen / Q000097:blood* / Q000652:urine*; D005343:Fibrinolytic Agents / Q000097:blood; D005921:Glomerulonephritis / Q000097:blood / Q000175:diagnosis* / Q000652:urine; D006386:Hemagglutination Tests; D006801:Humans; D007668:Kidney / Q000473:pathology; D008854:Microscopy, Electron; D011507:Proteinuria
D005343:Fibrinolytic Agents; D005337:Fibrin; D005340:Fibrinogen; D003404:Creatinine